EyePoint Pharmaceuticals

SEC Filing Details

Document Details

Form
Filing Date
Oct 15, 2019
Document Date
Oct 12, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EyePoint Pharmaceuticals, Inc.
Filer
LURKER NANCY
EyePoint Pharmaceuticals